N M Waite
Overview
Explore the profile of N M Waite including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
45
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Van Amburgh J, Waite N, Hobson E, Migden H
Pharmacotherapy
. 2001 Sep;
21(9):1115-22.
PMID: 11560201
Study Objective: To increase the rate of influenza vaccinations in high-risk patients by means of a pharmacist-managed immunization campaign. Design: Unblinded, single intervention. Setting: Rural primary care clinic. Patients: Six...
2.
Triller D, Hamilton R, Briceland L, Waite N, Audette C, Furman C
Am J Health Syst Pharm
. 2000 Aug;
57(14):1326-31.
PMID: 10918922
A clinical pharmacy program was developed at an established home health care (HHC) agency to demonstrate the need for clinical pharmacy services in the HHC population and to explore opportunities...
3.
Waite N, Webster N, Laurel M, Johnson M, Fong I
Am J Kidney Dis
. 1997 May;
29(5):763-8.
PMID: 9159313
Infections are the main complications of peritoneal dialysis, and currently there is no established method for prevention. A prospective, randomized, single-blind study was performed to evaluate the efficacy of regular...
4.
Waite N, Thomson L, Goldstein M
J Am Soc Nephrol
. 1995 May;
5(11):1930-4.
PMID: 7620090
Seventy-seven chronic hemodialysis patients were vaccinated against hepatitis B virus with an intramuscular (im) hepatitis B vaccine (HBV), 40 micrograms at 0, 1, 2, and 6 months. Fifty-seven patients (74%)...
5.
Waite N, Johnson M, Webster N, Fong I
Perit Dial Int
. 1993 Jan;
13(1):50-4.
PMID: 8443278
Objectives: To assess the clinical value of oral ciprofloxacin in the treatment of peritonitis in an intermittent peritoneal dialysis (IPD) population. Design: Open nonrandomized prospective study. Setting: Nephrology Peritoneal Dialysis...
6.
Waite N, Rybak M, Krakovsky D, Steinberg J, Warbasse L, Edwards D
Antimicrob Agents Chemother
. 1991 Jan;
35(1):130-4.
PMID: 2014968
Case reports suggest that the magnitude of inhibition of oxidative metabolism produced by ciprofloxacin may be greater in elderly subjects. We examined the effect of oral ciprofloxacin on antipyrine disposition...
7.
Waite N, Edwards D, Arnott W, Warbasse L
Antimicrob Agents Chemother
. 1989 Nov;
33(11):1875-7.
PMID: 2610498
Several inhibitors of oxidative drug metabolism inhibit the synthesis of endogenous compounds such as testosterone and cortisol. Since ciprofloxacin is a potent inhibitor of the metabolism of a number of...
8.
Edwards D, Waite N, Svensson C
Drug Metab Dispos
. 1988 Jul;
16(4):653-5.
PMID: 2903039
No abstract available.